Pulse Biosciences, Inc. (PLSE): Company Cash Volume

Official company branding of Pulse Corp (PLSE)

The current level of cash reserves on the GURU.Markets chart demonstrates a financial recovery for Pulse Biosciences, Inc. (PLSE), where the parameter mark equals 0.19. Growth is supported by strong pricing power driven by unique CellFX nanosecond pulses. External manufacturing plants and cloud services ensure development efficiency. The strategic vector is focused on the commercialization of cardiology systems, despite a temporary increase in personnel training costs.

Company Cash Funds: Pulse Medical (PLSE) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Pulse Biosciences Inc (PLSE)

- stock quotes and analyst forecast:
- stock exchange capitalization data:
Initial company analysis:Pulse Medical PLSE
Brand item of Pulse Biosciences

This metric reflects the volume of liquid assets, determining the issuer's ability to fund operating activities without resorting to external borrowing. For Pulse Biosciences, Inc. (PLSE), the history of cash holdings is critical, as the availability of reserves directly impacts the adoption rate of electroporation equipment amid clinic budget constraints, allowing investors to assess the sustainability of business scaling during economic downturns.

Analysis of competing companies

Company Cash Volume DXCM|Company Cash Volume penumbrainc.com (PEN)|Company Cash Volume NOVT (novanta.com)|Haemonetics Corp. - Company Cash Funds|INSP - Company Cash Funds|PRCT: Company Cash Funds|CNMD (CONMED Corporation) - Company Cash on Hand|InMode Ltd. - Company Cash Balance|Company Cash Funds picardmedical.com|Company Cash Reserve Surmodics Inc SRDX|Company Cash Funds senseonics.com (SENS)|NeuroPace, Inc. (NPCE) - Company Cash Position|Tactile Systems Technology, Inc. - Company Cash on Hand|Company Cash Volume Sanuwave Health Inc SNWV|OM - Company Cash Funds|Company Liquid Assets Electromed ELMD|LENSAR (LNSR) - Company Cash Funds|Company Total Cash Volume RCEL (AVITA Medical Inc)|Company Cash Funds profoundmedical.com|Company Cash on Hand Baird Medical Investment (BDMD)|Company Cash Volume EDAP|APYX - Company Cash Reserve|Company Cash Funds icecure-medical.com ICCM|LUNG: Company Cash and Cash Equivalents|TELA: Company Cash on Hand|cytosorbents.com - Company Total Cash Amount|Sensus Healthcare Inc (SRTS) - Company Cash Funds|Company Total Cash Volume ZYXI (Zynex Inc)|Company Cash Funds electroCore, Inc.|Vicarious Surgical Inc. (RBOT) - Company Liquid Assets|Company Cash Funds Inspira Technologies Oxy B.H.N. Ltd (IINN)|Company Liquid Assets SeaStar Medical|Company Cash Volume IRIX (iridex.com)|Intelligent Bio Solutions (INBS) - Company Cash Reserve|XAIR - Company Cash Funds|PFSA - Company Cash Volume|SSKN: Company Cash Volume|GCTK: Company Total Cash Amount|NAOV (NanoVibronix, Inc.) - Company Cash Volume|Company Cash on Hand Venus Concept Inc (VERO)|Company Cash Funds Nuwellis Corp (NUWE)|AEMD (Aethlon Medical Corp) - Company Cash Balance|Company Cash Funds asensus.com ASXC|Company Liquid Assets avinger.com (AVGR)|BioSig Technologies, Inc. - Company Cash Volume|Cutera, Inc (CUTR) - Company Cash on Hand|Know Labs, Inc. (KNW) - Company Cash Funds|Company Cash on Hand Inari|Company Cash Funds Nevro|Company Cash Reserve reshapelifesciences.com RSLS|Company Cash Volume SILK